SEC Filings TLDR

Lincoln Alternative Strategies LLC has filed a Schedule 13G with the SEC, disclosing a 9.94% ownership in Purple Biotech Ltd. The filing indicates that Lincoln Alternative Strategies LLC beneficially owns 605,000 American Depositary Shares (ADS), each representing 200 ordinary shares of Purple Biotech Ltd. The shares a...

Orca Capital AG, a German entity, has filed a Schedule 13G with the SEC, disclosing its ownership of 605,000 American Depositary Shares (ADS) of Purple Biotech Ltd., representing 9.9% of the outstanding shares. The filing indicates that Orca Capital AG has sole voting and dispositive power over these shares. The ADSs e...

Glazer Capital, LLC and Paul J. Glazer have filed a Schedule 13G with the SEC, disclosing their ownership of 2,474,820 shares of common stock in scPharmaceuticals Inc., representing 4.64% of the outstanding shares. The filing indicates that Glazer Capital and Mr. Glazer may have previously owned more than 5% of the sha...

Kingdon Capital Management, L.L.C., along with M. Kingdon Offshore Master Fund L.P., Kingdon GP, LLC, and Mark Kingdon, have filed a Schedule 13G indicating their ownership in enVVeno Medical Corporation. Kingdon Capital Management, L.L.C. owns 7.1% of the Common Stock, amounting to 1,359,261 shares, while M. Kingdon O...

JC Associates, Inc. has filed a Schedule 13G with the SEC, reporting a 34% ownership in CISO Global, Inc. The filing indicates that JC Associates, Inc. beneficially owns 3,117,340 shares of Series A Preferred stock in CISO Global, Inc. The shares are held with sole voting and dispositive power, and there are no shared ...

Prudential Financial, Inc. has filed a Schedule 13G with the SEC, disclosing its ownership of 5,300,000 shares of Tortoise Energy Infrastructure Corp's Mandatory Redeemable Preferred Stock, representing 82.9% of the outstanding shares. The filing indicates that Prudential Financial, Inc. has sole voting and dispositive...

Prudential Financial, Inc. has filed a Schedule 13G with the SEC, disclosing significant ownership in Tortoise Energy Infrastructure Corp. The filing reveals that Prudential Financial, Inc. owns 5,300,000 shares of Mandatory Redeemable Preferred Stock, representing 82.9% of the outstanding shares. This substantial owne...

T. Rowe Price Associates, Inc. has filed a Schedule 13G with the SEC, reporting a 12.8% ownership in Uranium Energy Corp. The filing indicates that T. Rowe Price Associates, Inc. beneficially owns 56,674,925 shares of common stock, with sole voting power over 54,504,875 shares and sole dispositive power over 56,673,868...

The Schedule 13G filing reports the beneficial ownership of Class A Common Stock of vTv Therapeutics Inc. by Invus Public Equities, L.P., and related entities. As of August 29, 2025, the Reporting Persons collectively beneficially owned 348,083 shares, representing 9.99% of the issued and outstanding shares. The filing...

Trails Edge Capital Partners, LP, along with Trails Edge Biotechnology Master Fund, LP and Ortav Yehudai, collectively known as the Filers, have reported a 9.9% beneficial ownership in vTv Therapeutics Inc. as of August 29, 2025. The ownership includes 340,536 shares of Class A common stock, consisting of 231,000 share...

Janus Henderson Group plc filed a Schedule 13G with the SEC, disclosing its beneficial ownership of 13.6% of Vistagen Therapeutics, Inc.'s common stock, amounting to 4,165,767 shares. The filing indicates that Janus Henderson Group plc, along with its indirect subsidiaries JHIUS, JHIUKL, and JHIAIFML, may be deemed the...

Bradley James Crosby has filed a Schedule 13G with the SEC, disclosing beneficial ownership of 1,217,063 shares of Class A Common Stock in SurgePays, Inc., representing 5.96% of the company's outstanding shares. The filing indicates that Crosby has sole voting and dispositive power over these shares. The filing is made...

CVI Investments, Inc. and Heights Capital Management, Inc. have jointly filed a Schedule 13G with the SEC, disclosing their beneficial ownership of 6.9% of the common stock of Strata Skin Sciences, Inc. The filing indicates that Heights Capital Management, Inc. serves as the investment manager for CVI Investments, Inc....

Whetstone Capital Advisors, LLC and David Atterbury have filed a Schedule 13G with the SEC, disclosing their beneficial ownership of 3,632,371 shares of Class A Common Stock of Sera Prognostics, Inc., representing 9.9% of the outstanding shares. The filing indicates that the shares are held for investment purposes and ...

Stonepine Capital Management, LLC, along with its affiliates Stonepine Capital, L.P., Stonepine GP, LLC, and Jon M. Plexico, have filed a Schedule 13G with the SEC regarding their ownership of Kezar Life Sciences, Inc. The filing indicates that these entities collectively own 377,240 shares of Kezar Life Sciences' comm...

Janus Henderson Group plc filed a Schedule 13G with the SEC, disclosing its beneficial ownership of 24,271,759 shares of common stock in Invivyd, Inc., representing 11.6% of the company's outstanding shares. The filing indicates that Janus Henderson Group plc, through its indirect subsidiaries JHIUS, JHIUKL, and JHIAIF...

Whetstone Capital Advisors, LLC and David Atterbury have filed a Schedule 13G with the SEC, disclosing their beneficial ownership of shares in Health Catalyst, Inc. The filing indicates that the reporting persons collectively own 3,731,350 shares of common stock, representing 5.4% of the total shares outstanding. The s...

FMR LLC has filed a Schedule 13G with the SEC, disclosing its ownership of 14.8% of the Class A Common Stock of GigaCloud Technology Inc. The filing indicates that FMR LLC beneficially owns 4,372,409.19 shares, with sole voting power over 4,370,087 shares and sole dispositive power over all 4,372,409.19 shares. The fil...

Morgan Stanley and Morgan Stanley Smith Barney LLC have filed a Schedule 13G with the SEC, disclosing their beneficial ownership of 10.5% of the common stock of Evoke Pharma Inc. The filing indicates that the shares are held in the ordinary course of business and not for the purpose of influencing the control of the is...

Hilve Holdings Limited and Mikhail Stiskin have filed a Schedule 13G with the SEC, reporting a 5.7% beneficial ownership in electroCore, Inc. Hilve Holdings Limited directly holds 432,000 shares of Common Stock, and Mikhail Stiskin, as the sole shareholder of Hilve Holdings Limited, may be deemed the beneficial owner o...

Farallon Capital Management, L.L.C. and its affiliated entities have filed a Schedule 13G with the SEC, disclosing their beneficial ownership of shares in Crinetics Pharmaceuticals, Inc. The filing includes multiple Farallon funds and individual reporting persons, who collectively own a significant percentage of the co...

This Schedule 13G filing is submitted on behalf of Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC, collectively referred to as the Reporting Persons. As of September 5, 2025, the Reporting Persons may have been deemed to beneficially own 143,336 shares of Common Stock of Applied DNA Sciences, Inc., re...

T. Rowe Price Investment Management, Inc. has filed a Schedule 13G with the SEC, reporting an 11.3% ownership in ARCELLX INC. The filing indicates that T. Rowe Price Investment Management, Inc. beneficially owns 6,275,907 shares of ARCELLX INC's common stock. Of these shares, 6,135,986 are held with sole voting power, ...

FIL Limited has filed a Schedule 13G with the SEC, disclosing its ownership of 4,682,087 shares of common stock in WNS Holdings Ltd, representing 10.9% of the total outstanding shares. The filing indicates that FIL Limited has sole voting power over 4,665,534 shares and sole dispositive power over all 4,682,087 shares....

Prudential Financial, Inc. has filed a Schedule 13G with the SEC, reporting an 82.9% ownership in Tortoise Energy Infrastructure Corp's Mandatory Redeemable Preferred Stock. The filing indicates that Prudential Financial, Inc. beneficially owns 5,300,000 shares, with sole voting and dispositive power over these shares....